Pyridoxine hydrochloride
Pyridoxine hydrochloride (vitamin B6) is used in haematology chiefly to treat pyridoxine-responsive sideroblastic anaemia and to prevent or correct deficiency, including isoniazid-induced deficiency.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is converted to pyridoxal phosphate, a coenzyme for amino acid metabolism and an early step in haem synthesis (delta-aminolaevulinic acid formation), which can improve haemoglobinisation in responsive sideroblastic anaemia.
Prescribing in practice
- Prolonged use of high doses can cause a peripheral sensory neuropathy, so avoid unnecessarily high or long-term dosing.
- Only a subset of sideroblastic anaemias are pyridoxine-responsive, so review the haematological response and stop if there is no benefit.
- It can reduce the efficacy of levodopa given without a dopa-decarboxylase inhibitor, so check concurrent therapy.
Monitoring
Monitor the full blood count and haemoglobin response in sideroblastic anaemia, and review for any sensory neuropathy with prolonged use.
Counselling the patient
- Take as directed and do not exceed the recommended amount because excess can affect the nerves.
- Report any numbness, tingling or unsteadiness in the hands or feet.
- Continued treatment depends on whether the blood count improves.
Evidence & guidelines
Pyridoxine is the recognised treatment for pyridoxine-responsive sideroblastic anaemia and for preventing isoniazid-induced deficiency.
Reference: NICE; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO